Compounds > cgp 12177

cgp 12177 and salmeterol xinafoate

cgp 12177 has been researched along with salmeterol xinafoate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, JG1
Charlton, SJ; Dickson, CJ; Duca, JS; Fairhurst, RA; Hornak, V; McKay, DJ; Pearlstein, RA; Reilly, J; Sandham, DA; Shaw, D; Sykes, DA; Velez-Vega, C1
Carter, AA; Hill, SJ1
Barrett, VJ; Emmons, AJ; Ford, AJ; Knowles, RG; Morrison, VS; Slack, RJ; Sturton, RG1

Other Studies

4 other study(ies) available for cgp 12177 and salmeterol xinafoate

ArticleYear
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    British journal of pharmacology, 2005, Volume: 144, Issue:3

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3

2005
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding.
    Journal of medicinal chemistry, 2016, 06-23, Volume: 59, Issue:12

    Topics: Binding Sites; Cell Membrane; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, Adrenergic, beta-2; Structure-Activity Relationship

2016
Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; beta-Galactosidase; Cell Line; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Genetic Complementation Test; Humans; Isoproterenol; Mutation; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Salmeterol Xinafoate; Transfection

2005
In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:1

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Albuterol; Animals; Benzyl Alcohols; Binding, Competitive; Cell Membrane; Cells, Cultured; Chlorobenzenes; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Data Interpretation, Statistical; Fluorescence Polarization; Guinea Pigs; Humans; Kinetics; Propanolamines; Pulmonary Disease, Chronic Obstructive; Radioligand Assay; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate

2013